Personal information

Websites & social links

LinkedIn

Other IDs

SciProfiles: 2027270
Scopus Author ID: 57208821495

Activities

Collapse all

Employment (3)

Fundación para la Investigación Sanitaria del Hospital La Princesa: Madrid, ES

2022-09-01 to present | Postdoctoral Researcher (Neuropharmacology)
Employment
Source: Self-asserted source
Inés Valencia

Universidad Autónoma de Madrid: Madrid, ES

2022-03-30 to 2022-08-31 | Postdoctoral Researcher (Pharmacology and Physiology)
Employment
Source: Self-asserted source
Inés Valencia

Universidad Autónoma de Madrid Facultad de Medicina: Madrid, Madrid, ES

2017-11 to 2022-03-29 | PDIF (Pharmacology)
Employment
Source: Self-asserted source
Inés Valencia

Education and qualifications (3)

Universidad Autónoma de Madrid: Madrid, ES

2017-11-01 to 2022-03-22 | PhD in Pharmacology and Physiology (Pharmacology and Physiology)
Education
Source: Self-asserted source
Inés Valencia

Universidad Autónoma de Madrid Facultad de Medicina: Madrid, Madrid, ES

2016-10 to 2017-09-19 | Master Degree in Pharmacological Research
Education
Source: Self-asserted source
Inés Valencia

Universidad Autonoma de Madrid Facultad de Ciencias: Madrid, Madrid, ES

2012-09 to 2016-06-08 | Bachelor of Biology
Education
Source: Self-asserted source
Inés Valencia

Works (10)

Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus

Cardiovascular Diabetology
2024 | Journal article
DOI: 10.1186/s12933-023-02097-8
EID:

2-s2.0-85185446442

Part of ISSN: 14752840
Contributors: Valencia, I.; Lumpuy-Castillo, J.; Magalhaes, G.; Sánchez-Ferrer, C.F.; Lorenzo, Ó.; Peiró, C.
Source: Self-asserted source
Inés Valencia via Scopus - Elsevier

Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4

Antioxidants
2023-09-07 | Journal article
DOI: 10.3390/antiox12091729
Contributors: Alejandra Palomino-Antolín; Céline Decouty-Pérez; Víctor Farré-Alins; Paloma Narros-Fernández; Ana Belen Lopez-Rodriguez; María Álvarez-Rubal; Inés Valencia; Francisco López-Muñoz; Eva Ramos; Antonio Cuadrado et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation

Biochemical Pharmacology
2022 | Journal article
DOI: 10.1016/j.bcp.2022.115078
EID:

2-s2.0-85130822592

Part of ISSN: 18732968 00062952
Contributors: Shamoon, L.; Espitia-Corredor, J.A.; Dongil, P.; Menéndez-Ribes, M.; Romero, A.; Valencia, I.; Díaz-Araya, G.; Sánchez-Ferrer, C.F.; Peiró, C.
Source: Self-asserted source
Inés Valencia via Scopus - Elsevier

DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation

Hypertension
2022-07 | Journal article
DOI: 10.1161/HYPERTENSIONAHA.121.18477
Contributors: Inés Valencia; Susana Vallejo; Pilar Dongil; Alejandra Romero; Álvaro San Hipólito-Luengo; Licia Shamoon; María Posada; Damián García-Olmo; Raffaelle Carraro; Jorge D. Erusalimsky et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Angiotensin-(1-7), a protective peptide against vascular aging

Peptides
2022-02 | Journal article
DOI: 10.1016/j.peptides.2022.170775
Part of ISSN: 0196-9781
Source: Self-asserted source
Inés Valencia

Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction

Aging and disease
2022-02-01 | Journal article
DOI: 10.14336/ad.2021.0617
Part of ISSN: 2152-5250
PMID: 35111374
Source: Self-asserted source
Inés Valencia
grade
Preferred source (of 2)‎

NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically

Antioxidants
2022-01 | Journal article | Author
DOI: 10.3390/antiox11020269
Contributors: Ainara González-Moro; Inés Valencia; Licia Shamoon; Carlos Félix Sánchez-Ferrer; Concepción Peiró; Fernando De la Cuesta
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Frontiers in pharmacology
2020-08-07 | Journal article
DOI: 10.3389/fphar.2020.01161
PMID: 32848769
PMC: PMC7426477
Source: Self-asserted source
Inés Valencia
grade
Preferred source (of 2)‎

Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.

Scientific reports
2020-03-25 | Journal article
DOI: 10.1038/s41598-020-62190-w
PMID: 32214150
PMC: PMC7096459
Source: Self-asserted source
Inés Valencia
grade
Preferred source (of 2)‎

The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation.

Aging cell
2019-02-17 | Journal article
DOI: 10.1111/acel.12913
PMID: 30773786
PMC: PMC6516147
Source: Self-asserted source
Inés Valencia
grade
Preferred source (of 2)‎

Peer review (5 reviews for 2 publications/grants)

Review activity for Burns. (1)
Review activity for Heliyon. (4)
How many people are using ORCID?